eMedevents

Incorporating Novel Treatment Approaches into Clinical Pathways in AML is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Nov 21, 2018 - Nov 21, 2019.

Intended Learners:
This activity is designed for directors of oncology practice programs and cancer centres, oncologists, haematologists, commercial and government payers, pathway development executives, reimbursement specialists, speciality pharmacists, HEOR specialists, and other healthcare professionals interested in learning how to implement, integrate, and measure treatment pathways.

Accreditation:
CME:
Naccme Designates This Enduring Material For A Maximum Of 1.00 Ama Pra Category 1 Credits™. Physicians Should Claim Only The Credit Commensurate With The Extent Of Their Participation In The Activity.

Physician Assistants: Naccme Has Been Authorized By The American Academy Of Pas (Aapa) To Award Aapa Category 1 CME Credit For Activities Planned In Accordance With The Aapa Cme Criteria. This Activity Is Designated For 1.00 Aapa Category 1 Credit(S). Pas Should Only Claim Credit Commensurate With The Extent Of Their Participation In The Activity.

CNE: This Continuing Nursing Education Activity Awards 1.00 Contact Hours. Provider Approved By The California Board Of Registered Nursing, Provider #13255 For 1.50 Contact Hours.

Nursing Pharmacology Hours: This Continuing Nursing Educational Activity Awards Up To 1.00 Pharmacology Hours.

Learning Objectives:
After Completing This Activity, Participants Should Be Able To:
• Characterize the downstream clinical and economic burdens of suboptimal AML treatment and the potential impact of integrating new and emerging treatments into pathways
• Review design and implementation strategies for clinical pathways that offer flexibility to account for patient age, comorbidities, genetics, and treatment setting
• Appraise the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors • for informed pathway placement
• Integrate recent therapeutic advances, available resource utilization data, and current clinical guidance into AML clinical pathways discussions

Activity Overview:
• This on-demand webcast is available with synchronized slides and audio.
• To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.
• After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
• Participants who completed the live version of this activity are not eligible to receive credit for this enduring material.

Intended Audience

Oncology, Hematopathology

Activity Payment Details

Activity Fee : Free

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

Healthcare Made Practical (HMP) Communications LLC

View Organizer Details

Help

610.560.0500